403 related articles for article (PubMed ID: 12184059)
1. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
Esler M
J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
3. High blood pressure management: potential benefits of I1 agents.
Esler M
J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.
Krum H; Lambert E; Windebank E; Campbell DJ; Esler M
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1706-12. PubMed ID: 16284232
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin blockade with eprosartan: vascular and functional implications.
Ram CV
Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S5-11. PubMed ID: 18093408
[TBL] [Abstract][Full Text] [Related]
6. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
Chikhladze NM
Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
[No Abstract] [Full Text] [Related]
7. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
[TBL] [Abstract][Full Text] [Related]
8. The clinical profile of the angiotensin II receptor blocker eprosartan.
Hedner T
J Hypertens Suppl; 2002 Jun; 20(5):S33-8. PubMed ID: 12184062
[TBL] [Abstract][Full Text] [Related]
9. Effects of antihypertensive therapies on the sympathetic nervous system.
de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
[TBL] [Abstract][Full Text] [Related]
10. The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats.
Anderson IK; Drew GM
Br J Pharmacol; 1998 Nov; 125(6):1236-46. PubMed ID: 9863652
[TBL] [Abstract][Full Text] [Related]
11. Noradrenaline spillover and microneurography measurements in patients with primary hypertension.
Jennings GL
J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
Chang PC; Kriek E; van Brummelen P
J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of essential hypertension. Plasma noradrenaline, plasma renin and pressor effects of noradrenaline and angiotensin in normotensive patients and patients with essential hypertension].
Philipp T
Fortschr Med; 1979 Aug; 97(30-31):1315-20. PubMed ID: 468094
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
[TBL] [Abstract][Full Text] [Related]
15. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
16. Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.
Nap A; Belterman CN; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):220-7. PubMed ID: 14689369
[TBL] [Abstract][Full Text] [Related]
17. Risk reduction by preventing stroke: need for blockade of angiotensin II and catecholamines?
Rupp H
Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S25-9. PubMed ID: 18093411
[TBL] [Abstract][Full Text] [Related]
18. The role of angiotensin II receptors and their antagonists in hypertension.
van Zwieten PA
Ann Ital Med Int; 2000; 15(1):85-91. PubMed ID: 10842896
[TBL] [Abstract][Full Text] [Related]
19. Elevated sympathetic nerve activity in patients with accelerated essential hypertension.
Matsukawa T; Mano T; Gotoh E; Ishii M
J Clin Invest; 1993 Jul; 92(1):25-8. PubMed ID: 8325991
[TBL] [Abstract][Full Text] [Related]
20. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
Esler M; Kaye D
J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
